The clinicians, treatment planners, lab and coordinators behind your cases, all in one team, all in one country. The person who plans your case is the person you call. No ticket queue. No junior triaging your message before it lands with someone qualified to answer it.

Mia co-founder, still running Mia Aligner cases in her own practice today. Drives the clinical standard with a passion for South Africa, aesthetic dentistry and serving her patients with the best possible treatments.

The latest addition to our team, stepping in as leading orthodontist after one of our founding members: Dr Petra van der Merwe, moved to Namibia. Brings a wealth of experience in both fixed and aligner treatments, and is here to guide the team.

The doyen of South African ortho-lab products. Developed the country’s first aligner system with Dr Mark Bowes over 15 years ago, that depth of knowledge, case history and market-leading orthodontic-treatment integrations now sits behind every Mia case.

Worked alongside Dr Petra for years on all her cases and became deeply specialised in the planning software, all the tricks and AI protocols that bring your smiles to life. Creative yet responsible, with the judgement to add real value to your practice.

Treatment planner out of the Adam Labs team. Day-to-day output, scan-to-plan workflow, attachment placement, staging, and the back-and-forth on plan revisions until it’s right.

The person who keeps your account moving, onboarding, case status, refinement requests, peer-event invites and support escalation. The single point of contact when you need something done.
Clinicians, treatment planners, lab and coordinators, all in one team, all on local time. See the full Mia team
You’re already doing aligners, you don’t need persuading on the concept. The honest question is whether your current system treats you like a partner, or like an account to be managed.
Pushy sales cycles. Aggressive case-recall pressure. Discount tiers that quietly disappear if you don’t hit targets you didn’t help set, which can nudge you toward case acceptance you’d otherwise refer out.
No quotas. No annual minimums. No recalls of your discount tier because you didn’t hit a number. Your patients’ needs and case selection stay your own, never pressured.
You watched another international clear-aligner brand exit South Africa quietly. Practices were left mid-treatment, scrambling for refinements, explaining to patients why their plans were now stranded. The market still hasn't fully forgotten.
No corporate parent that could decide SA isn’t strategic. SA-owned, SA-clinical, SA-manufactured. Cape Town is the only home we have, not a regional office we can close.
Planning communication takes days to come back, and shipping even longer. Mid-case questions land in ticket queues. The “support team” you can reach is a customer-success generalist abroad, not the clinician or planner who built your case. Your patient is in the chair next Thursday.
Direct WhatsApp to the team who planned your case. SA time zone. Voice notes and calls when text isn’t enough or you don’t have time.
All the big international brands have sales teams and local doctor reps here, that part isn’t the problem. The problem is when everyone else behind the case lives across an ocean. Treatment planners abroad. Manufacturers abroad. Clinical escalation paths that route through a foreign HQ before anyone calls you back.
Our whole team is here. Clinicians, treatment planners, manufacturers, account coordinators, sales and support, all on local time, all in the same building or a WhatsApp away. The case goes from your scan to your patient’s chair without leaving the country.
Every system claims to be the answer. They all ship the same workflow, the same case-acceptance rules, the same turnaround cadence, the same refinement policy, written for an “average” practice that doesn’t look much like yours. As a high producer you’ve been adapting around someone else’s product roadmap for years instead of the other way around.
Bespoke systems for high producers. Tell us what isn’t working in how you currently run aligners, treatment protocol, turnaround windows, refinement triggers, account workflow, patient experience touches, and we’ll build the system around you. The product roadmap stays ours; the workflow becomes yours.
If any of those land too close to home, let's talk.
Book your Account Discovery CallThe metrics that actually matter to a high-volume aligner practitioner, refinement rates, precision, turnaround, support model.
vs 50% international industry. At your volume that gap is the difference between margin and rework.
Same precision used by the market leader. The clinical output is parity. The relationship isn’t.
Local production. Days, not weeks. Refinements move at the same speed.
No annual minimums. No discount recalls. Your case selection stays your own.
Every aligner case is planned and approved by an HPCSA-registered clinician, no algorithm-only plans. The treatment protocols were built by Dr Petra van der Merwe across thousands of South African mouths, then made even sharper by the latest AI orthodontic tech from SoftSmile, trained on those same Mia protocols.
Worth a 30-minute call to see if it's the better partner for your volume?
Book your Account Discovery CallAcross the clinical leads (Dr Karishma Soni and Dr Ismail Amra) and the treatment-planning bench (Bernice, Diyanah and the wider team), Mia has worked on more than twenty thousand aligner cases, from the simplest single-arch alignment to multi-arch extraction-based and pre-prosthetic complex work. Every case sharpens the protocol. The next one we plan together draws on all of them.
The AI orthodontic technology in our planning workflow doesn’t replace the team, it amplifies them. Dr Karishma Soni’s chairside practice, Dr Ismail Amra’s career in orthodontics, Dr Petra van der Merwe’s foundational SA aligner-system work, Adam Botha’s 15 years of ortho-lab depth: the team’s real experience with real South African patients is the input. The technology is just the leverage on top.
Soni in practice today. Amra leading orthodontics. Petra building the foundation. Adam Botha’s 15-year lab history. Bernice’s deep planning fluency. 20,000+ cases across the team, all on local case mix, that’s the input.
The treatment-planning rules, refinement triggers, attachment libraries and staging logic written down across thousands of cases. Treatment protocols built by Dr Petra van der Merwe, still the spine of every plan we ship.
SoftSmile’s AI orthodontic platform reads scans and surfaces treatment options at speed. Critically: it’s trained on our protocols. The output you see was shaped by SA clinical judgement long before the model touched it.
SoftSmile Vision →
A founding member of Mia and instrumental in bringing this product to market. The treatment-planning protocols, refinement policies and case-selection logic Petra built across thousands of South African cases still sit behind every Mia plan today, and were the training data the AI orthodontic tools we use have been shaped against.
Recently relocated to Namibia · protocols and influence remain core to Mia
Six specifications that matter chairside. Same precision, same biocompatibility, same attachment discipline as the market-leading aligner systems, with the SA-adapted protocols and turnaround that the international players can’t match.
Biocompatible aligner material, FDA-cleared for orthodontic use. Same thermoforming class as the leading global systems.
Layer height on the production prints, equivalent to the market-leading aligner manufacturing precision.
Industry-standard thickness for tracking and patient comfort. Variants available on request for unusual cases.
Optimised attachments for rotation, root control, extrusion, intrusion and bodily movement. Standard set + bespoke options on complex cases.
Standard refinements included in case price. Re-scan, re-plan, re-print, no upcharge games. Plan adjustments stay clinical, not commercial.
Every plan is reviewed by an HPCSA-registered clinician before it ships. No algorithm-only plans. No black-box AI deciding without sign-off.
Most clear-aligner systems available in SA are owned by global dental conglomerates headquartered in the US, Europe or Israel. South Africa is a small slice of their global P&L, a slice that can be re-allocated, deprioritised, or quietly exited when corporate strategy shifts. Mia isn’t built that way.
R&D, treatment-planning protocols and clinical IP are SA-based.
Aligner production runs at Adam Labs, in-house, no overseas shipping cycle.
A South African clinical team, registered with HPCSA and SADA, on local time.
No foreign parent. No quarterly board meeting deciding whether SA is “still strategic.”
Practice visits, peer-review groups, CPD events, all hosted in South Africa.
Plant-based resins. Recyclable production workflow. A smaller carbon footprint.
Six structural changes to the way you work with an aligner provider. Plus access to our CPD-bearing education library, included from day one.
No ticket queues. No support tiers. The senior clinician who planned your case is the person who picks up the phone.
Local manufacturing means days, not weeks. Refinements move at the same speed.
Volume terms negotiated once with you, and held even if you slow down for a quarter. No quota pressure.
Optional co-branded packaging, premium retention kits, post-treatment care touches that reflect your practice's brand.
Team lunch-and-learns. Complex-case workshops. Peer reviews hosted at your practice, by clinicians in your time zone.
A community of South African Mia aligner practitioners. Case-sharing groups, in-person events, clinical study clubs.
What aligner practitioners want clarity on before switching, pricing, transition risk, clinical control, and what happens if it doesn’t work out.
Mia’s case pricing is competitive with leading international systems, usually meaningfully better at your volume, with no quota-tier games. The specific number depends on case mix, monthly volume and patient-experience options. We give you the actual numbers on the Discovery Call once we’ve seen your typical case mix, not a quote-form auto-reply.
Your existing cases finish on the system they started on, no interruption, no patient drama. Mia onboards new cases progressively as you start them, so the switch is a gradient not a cliff. Many switchers run two systems in parallel for the first 3 to 6 months, then naturally consolidate. There’s no exclusivity clause.
Yes, on the dimensions that affect outcomes. 99 µm print precision, biocompatible aligner material, every plan reviewed by an HPCSA-registered clinician (no algorithm-only plans). Our refinement rate sits at 23% versus the ~50% international industry average. The clinical IP is SA, pressure-tested across 20,000+ cases.
Our team will pull in experts onto your complex cases, they can assist with planning and clinical direction, voice-note debate the staging, and stay in the loop through refinements. You’re never alone on the harder ones.
Because we’re a clinician-led company, not a commercial pipeline backed by quarterly investor calls. We make the model work on your real volume, whatever that is, not by pushing you to inflate it. Discount tiers don’t reset because you took maternity leave or had a slow quarter. The honest trade-off: we won’t be the cheapest at massive international-tier volumes. We will be the steadier partner over a decade.
For our high producers, if there’s something you don’t like, we’ll build systems around you. Treatment protocol, turnaround protocol, clinical support, account workflow. Tell us what isn’t working and let’s build a bespoke system for your practice. The relationship is the partnership.
Still weighing it up? Ask us directly on the call.
A 30-minute call with one of our senior clinicians. Honest conversation about your current workflow, the friction you're hitting, and whether Mia is the better partner for your volume. No pitch deck. No follow-up campaign if it isn't a fit.
We respond within one business day. POPIA-compliant. Never shared.